“…[2] As a subclass of substituted cyclopropanes, aminocyclopropanes are founda sk ey structural motifs in severalb ioactive compounds, among which the monoamine oxidaseinhibitor tranylcypromine is aw ell-known representative. [3] Additional examples include the antiplatelet drugticagrelor, [4] the non-nucleosidic inhibitor of HIV-1 reverse transcriptase MIV-150, [5] the proteasome inhibitor belactosin A, [6] and the hepatitis Cv irus NS3/ 4A protease inhibitor simeprevir [7] (Figure1). Numerous methods are available fort he synthesis of aminocyclopropanes, [8] either from substrates incorporating at hreemembered ring (Curtius rearrangemento fc yclopropanecarboxylic acid or its derivatives, [8,9] addition of nitrogen nucleophiles to cyclopropanone derivatives, [10] cyclopropenes [11] or alkylidene cyclopropanes, [12] and aminationo fo rganometallic cyclopropyl species), [13] or by construction of the amino-substituted ring (by intramolecular nucleophilic substitution, [14] cyclopropanation of enamides, [15] Kulinkovich-type reactions involving amides [16] or nitriles, [17] cyclopropanation of alkenes with a-nitrocarbenoids [18] or a-aminoc arbenes/carbenoids). [19] This research field remains active as illustrated by the recent development of an ew approachr elying on the reactiono f zinc homoenolates, generated in situ from cyclopropanols, with amines.…”